Drug Database
Back to search

Switzerland· 45215024

Dantamacrin 50 mg, Kapseln

A dantrolene product containing dantrolenum natricum hemiheptahydricum, registered in Switzerland by Norgine AG and dispensed under Swissmedic category B. The same ATC class is registered in 16 of our 19 countries.

Cat B (Swissmedic)ATC M03CA01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedDantamacrin 50 mg, KapselnATCM03CA01REGISTER NO.45215024PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dantrolenum natricum hemiheptahydricumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dantrolene is registered in 16 of 19 countries.

Countries holding a registration under ATC M03CA01 (dantrolene), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose
Search dantrolene products by name

Dantrolene · ATC M03CA01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dantrolene costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $1.64 in United States to $5.92 in Finland — a ×3.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Dantrolene · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • FI Finland$5.92
  • US United States$1.64 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
dantrolenum natricum hemiheptahydricum
Manufacturer
Norgine AG
Country
Switzerland (CH)
ATC code
M03CA01
ATC class
Dantrolene
Defined daily dose
0.1 g, O
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

93 interactions on record for dantrolene.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dantrolene against other medicinesHow interaction checks work

Dantrolene · interactions on record

93 records

  • 16 severe
  • 60 moderate
  • 17 info

Most severe, free to view

  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • EthinylestradiolG03CA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dantrolene in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dantrolene products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Belgium · Dantrium Iv
  • Germany · Dantamacrin, Dantrolen I.V.
  • France · Dantrium, Dantrium Intraveineux
  • United Kingdom (Northern Ireland) · Agilus, ​dantrium
  • Ireland · Dantrium
  • Iceland · Agilus
  • Italy · Dantrium
  • Liechtenstein · Agilus
  • Netherlands · Dantrium
  • Norway · Agilus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e00ea7ee-e762-4755-9224-4bde83147c49
GET /v1/drugs/e00ea7ee-e762-4755-9224-4bde83147c49?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about dantrolene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console